Percutaneous Coronary Intervention Market Research Report - Global Forecast till 2027

Globaler Markt für perkutane Koronarinterventionen: Informationen nach Produkttyp (Koronarstents, PTCA-Katheter, Koronarführungsdraht und Zubehör), nach Endverbraucher (Krankenhäuser und Spezialkliniken, ambulante chirurgische Zentren, Forschungs- und akademische Institute und andere) und nach Regionen (Amerika, Europa, Asien- Pazifik und Mittlerer Osten & Afrika) - Prognose bis 2027

ID: MRFR/MED/2288-CR | July 2019 | Region: Global | 157 Pages         

1 Report Prologue

2 Executive Summary

3 Introduction

3.1 Definition 20

3.2 Scope Of The Study 20

3.3 Assumptions & Limitations 21

3.4 Market Structure 21

4 Research Methodology

4.1 Research Process 23

4.2 Primary Research 24

4.3 Secondary Research 25

4.4 Market Size Estimation 25

4.5 Forecast Model 26

5 Market Dynamics

5.1 Introduction 28

5.2 Drivers 29

5.2.1 Rising Prevalence Of Heart Diseases 29

5.2.2 Increasing Preference For Minimally Invasive Procedures 29

5.2.3 Increasing Geriatric Population 29

5.3 Restraints 30

5.3.1 Risk Of Infection 30

5.3.2 Stringent Government Regulations 30

5.4 Opportunities 30

5.4.1 Favorable Reimbursement Scenario 30

6 Market Factor Analysis

6.1 Value Chain Analysis 32

6.1.1 Research And Development 32

6.1.2 Manufacturing 32

6.1.3 Distribution & Sales 32

6.1.4 Post-Sales Monitoring 32

6.2 Porter’s Five Forces Model 33

6.2.1 Bargaining Power Of Suppliers 33

6.2.2 Bargaining Power Of Buyers 34

6.2.3 Threat Of New Entrants 34

6.2.4 Threat Of Substitutes 34

6.2.5 Intense Rivalry 34

6.3 Investment Opportunity Analysis 34

6.4 Pricing Analysis 35

6.5 Market Volume By Product Type 35

7 Global Percutaneous Coronary Intervention Market By Product Type

7.1 Overview 37

7.2 Coronary Stents 38

7.3 PTCA Catheters 39

7.4 Coronary Guidewire 40

7.5 Accessories 40

8 Global Percutaneous Coronary Intervention Market By End-User

8.1 Overview 43

8.2 Hospitals & Specialty Clinics 44

8.3 Ambulatory Surgical Centers 44

8.4 Research And Academic Institutes 45

8.5 Others 45

9 Global Percutaneous Coronary Intervention Market By Region

9.1 Overview 47

9.2 Americas 49

9.2.1 North America 52

9.2.1.1 US 54

9.2.1.2 Canada 56

9.2.2 South America 57

9.3 Europe 60

9.3.1 Western Europe 63

9.3.1.1 Germany 65

9.3.1.2 France 67

9.3.1.3 UK 68

9.3.1.4 Italy 70

9.3.1.5 Spain 72

9.3.1.6 Rest Of Western Europe 73

9.3.2 Eastern Europe 75

9.4 Asia-Pacific 77

9.4.1 Japan 79

9.4.2 China 81

9.4.3 India 83

9.4.4 South Korea 84

9.4.5 Australia 86

9.4.6 Rest Of Asia-Pacific 88

9.5 Middle East & Africa 90

9.5.1 Middle East 92

9.5.2 Africa 94

10 Competitive Landscape

10.1 Introduction 97

10.2 Company Market Share Analysis 97

11 Company Profile

11.1 Abbott 100

11.1.1 Company Overview 100

11.1.2 Financial Overview 100

11.1.3 Products Offering 101

11.1.4 SWOT Analysis 101

11.1.5 Key Developments 101

11.1.6 Key Strategy 101

11.2 ASAHI INTECC Company Limited 102

11.2.1 Company Overview 102

11.2.2 Financial Overview 102

11.2.3 Key Developments 103

11.2.4 SWOT Analysis 104

11.2.5 Key Strategy 104

11.3 B. Braun Melsungen AG 105

11.3.1 Company Overview 105

11.3.2 Financial Overview 105

11.3.3 Products Offering 106

11.3.4 SWOT Analysis 107

11.3.5 Key Developments 107

11.3.6 Key Strategy 107

11.4 Biosensors International Group, Ltd. 108

11.4.1 Company Overview 108

11.4.2 Financial Overview 108

11.4.3 Products Offering 108

11.4.4 SWOT Analysis 108

11.4.5 Key Developments 108

11.4.6 Key Strategy 108

11.5 BIOTRONIK 109

11.5.1 Company Overview 109

11.5.2 Products Offering 109

11.5.3 SWOT Analysis 109

11.5.4 Key Developments 110

11.5.5 Key Strategy 110

11.6 Boston Scientific Corporation 111

11.6.1 Company Overview 111

11.6.2 Financial Overview 111

11.6.3 Products Offering 112

11.6.4 Key Developments 112

11.6.5 SWOT Analysis 113

11.6.6 Key Strategy 113

11.7 C. R. Bard, Inc. 114

11.7.1 Company Overview 114

11.7.2 Financial Overview 114

11.7.3 Products Offering 115

11.7.4 Key Developments 115

11.7.5 SWOT Analysis 115

11.7.6 Key Strategy 116

11.8 Comed BV. 117

11.8.1 Company Overview 117

11.8.2 Financial Overview 117

11.8.3 Products Offering 117

11.8.4 SWOT Analysis 118

11.8.5 Key Developments 118

11.8.6 Key Strategy 118

11.9 Cook 119

11.9.1 Company Overview 119

11.9.2 Financial Overview 119

11.9.3 Products Offering 119

11.9.4 SWOT Analysis 119

11.9.5 Key Developments 120

11.9.6 Key Strategy 120

11.10 Cordis 121

11.10.1 Company Overview 121

11.10.2 Financial Overview 121

11.10.3 Products Offering 122

11.10.4 SWOT Analysis 122

11.10.5 Key Development 122

11.10.6 Key Strategy 122

11.11 Medtronic PLC 123

11.11.1 Company Overview 123

11.11.2 Financial Overview 123

11.11.3 Products Offering 124

11.11.4 Key Developments 124

11.11.5 SWOT Analysis 124

11.11.6 Key Strategy 125

11.12 Meril Lifesciences Pvt. Ltd 126

11.12.1 Company Overview 126

11.12.2 Financial Overview 126

11.12.4 Key Developments 126

11.12.5 SWOT Analysis 127

11.12.6 Key Strategy 127

11.13 Merit Medical System 128

11.13.1 Company Overview 128

11.13.2 Financial Overview 128

11.13.3 Products Offering 129

11.13.4 Key Developments 129

11.13.5 SWOT Analysis 130

11.13.6 Key Strategy 130

11.14 Terumo Corporation 131

11.14.1 Company Overview 131

11.14.2 Financial Overview 131

11.14.3 Products Offering 132

11.14.4 Key Developments 132

11.14.5 SWOT Analysis 133

11.14.6 Key Strategy 133

12 Appendix

12.1 Discussion Blue Print 135

13 List Of Tables

TABLE 1 MARKET SYNOPSIS 18

TABLE 2 LIST OF ASSUMPTIONS 21

TABLE 3 PRIMARY INTERVIEWS 23

TABLE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET 33

TABLE 5 GLOBAL PCI MARKET VOLUME BY PRODUCT TYPE, 2020 (UNIT) 35

TABLE 6 GLOBAL PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 37

TABLE 7 GLOBAL PCI MARKET FOR CORONARY STENTS BY REGION, 2020 TO 2027 (USD MILLION) 38

TABLE 8 GLOBAL PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 38

TABLE 9 GLOBAL PCI MARKET FOR PTCA CATHETERS BY REGION, 2020 TO 2027 (USD MILLION) 39

TABLE 10 GLOBAL PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 39

TABLE 11 GLOBAL PCI MARKET FOR CORONARY GUIDEWIRE BY REGION, 2020 TO 2027 (USD MILLION) 40

TABLE 12 GLOBAL PCI MARKET FOR ACCESSORIES BY REGION, 2020 TO 2027 (USD MILLION) 40

TABLE 13 GLOBAL PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 41

TABLE 14 GLOBAL PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 43

TABLE 15 GLOBAL PCI MARKET FOR HOSPITALS & SPECIALTY CLINICS BY REGION, 2020 TO 2027 (USD MILLION) 44

TABLE 16 GLOBAL PCI MARKET FOR AMBULATORY SURGICAL CENTERS BY REGION, 2020 TO 2027 (USD MILLION) 44

TABLE 17 GLOBAL PCI MARKET FOR RESEARCH AND ACADEMIC INSTITUTES BY REGION, 2020 TO 2027 (USD MILLION) 45

TABLE 18 GLOBAL PCI MARKET BY REGION, 2020 TO 2027 (USD MILLION) 48

TABLE 19 AMERICAS PCI MARKET BY REGION, 2020 & 2027 (USD MILLION) 49

TABLE 20 AMERICAS PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 50

TABLE 21 AMERICAS PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 50

TABLE 22 AMERICAS PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 50

TABLE 23 AMERICAS PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 51

TABLE 24 AMERICAS PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 51

TABLE 25 NORTH AMERICA PCI MARKET BY COUNTRY, 2020 & 2027 (USD MILLION) 52

TABLE 26 NORTH AMERICA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 52

TABLE 27 NORTH AMERICA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 53

TABLE 28 NORTH AMERICA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 53

TABLE 29 NORTH AMERICA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 53

TABLE 30 NORTH AMERICA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 54

TABLE 31 US PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 54

TABLE 32 US PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 54

TABLE 33 US PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 55

TABLE 34 US PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 55

TABLE 35 US PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 55

TABLE 36 CANADA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 56

TABLE 37 CANADA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 56

TABLE 38 CANADA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 56

TABLE 39 CANADA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 57

TABLE 40 CANADA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 57

TABLE 41 SOUTH AMERICA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 57

TABLE 42 SOUTH AMERICA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 58

TABLE 43 SOUTH AMERICA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 58

TABLE 44 SOUTH AMERICA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 58

TABLE 45 SOUTH AMERICA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 59

TABLE 46 EUROPE PCI MARKET BY REGION, 2020 & 2027 (USD MILLION) 60

TABLE 47 EUROPE PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 61

TABLE 48 EUROPE PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 61

TABLE 49 EUROPE PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 61

TABLE 50 EUROPE PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 62

TABLE 51 EUROPE PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 62

TABLE 52 WESTERN EUROPE PCI MARKET BY COUNTRY, 2020 & 2027 (USD MILLION) 63

TABLE 53 WESTERN EUROPE PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 63

TABLE 54 WESTERN EUROPE PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 64

TABLE 55 WESTERN EUROPE PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 64

TABLE 56 WESTERN EUROPE PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 64

TABLE 57 WESTERN EUROPE PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 65

TABLE 58 GERMANY PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 65

TABLE 59 GERMANY PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 65

TABLE 60 GERMANY PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 66

TABLE 61 GERMANY PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 66

TABLE 62 GERMANY PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 66

TABLE 63 FRANCE PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 67

TABLE 64 FRANCE PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 67

TABLE 65 FRANCE PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 67

TABLE 66 FRANCE PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 68

TABLE 67 FRANCE PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 68

TABLE 68 UK PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 68

TABLE 69 UK PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 69

TABLE 70 UK PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 69

TABLE 71 UK PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 69

TABLE 72 UK PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 70

TABLE 73 ITALY PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 70

TABLE 74 ITALY PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 70

TABLE 75 ITALY PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 71

TABLE 76 ITALY PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 71

TABLE 77 ITALY PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 71

TABLE 78 SPAIN PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 72

TABLE 79 SPAIN PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 72

TABLE 80 SPAIN PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 72

TABLE 81 SPAIN PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 73

TABLE 82 SPAIN PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 73

TABLE 83 REST OF WESTERN EUROPE PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 73

TABLE 84 REST OF WESTERN EUROPE PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 74

TABLE 85 REST OF WESTERN EUROPE PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 74

TABLE 86 REST OF WESTERN EUROPE PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 74

TABLE 87 REST OF WESTERN EUROPE PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 75

TABLE 88 EASTERN EUROPE PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 75

TABLE 89 EASTERN EUROPE PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 75

TABLE 90 EASTERN EUROPE PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 76

TABLE 91 EASTERN EUROPE PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 76

TABLE 92 EASTERN EUROPE PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 76

TABLE 93 ASIA-PACIFIC PCI MARKET BY COUNTRY, 2020 & 2027 (USD MILLION) 77

TABLE 94 ASIA-PACIFIC PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 78

TABLE 95 ASIA-PACIFIC PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 78

TABLE 96 ASIA-PACIFIC PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 78

TABLE 97 ASIA-PACIFIC PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 79

TABLE 98 ASIA-PACIFIC PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 79

TABLE 99 JAPAN PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 79

TABLE 100 JAPAN PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 80

TABLE 101 JAPAN PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 80

TABLE 102 JAPAN PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 80

TABLE 103 JAPAN PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 81

TABLE 104 CHINA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 81

TABLE 105 CHINA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 81

TABLE 106 CHINA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 82

TABLE 107 CHINA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 82

TABLE 108 CHINA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 82

TABLE 109 INDIA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 83

TABLE 110 INDIA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 83

TABLE 111 INDIA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 83

TABLE 112 INDIA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 84

TABLE 113 INDIA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 84

TABLE 114 SOUTH KOREA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 84

TABLE 115 SOUTH KOREA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 85

TABLE 116 SOUTH KOREA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 85

TABLE 117 SOUTH KOREA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 85

TABLE 118 SOUTH KOREA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 86

TABLE 119 AUSTRALIA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 86

TABLE 120 AUSTRALIA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 86

TABLE 121 AUSTRALIA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 87

TABLE 122 AUSTRALIA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 87

TABLE 123 AUSTRALIA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 87

TABLE 124 REST OF ASIA-PACIFIC PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 88

TABLE 125 REST OF ASIA-PACIFIC PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 88

TABLE 126 REST OF ASIA-PACIFIC PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 88

TABLE 127 REST OF ASIA-PACIFIC PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 89

TABLE 128 REST OF ASIA-PACIFIC PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 89

TABLE 129 MIDDLE EAST & AFRICA PCI MARKET BY REGION, 2020 & 2027 (USD MILLION) 90

TABLE 130 MIDDLE EAST & AFRICA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 91

TABLE 131 MIDDLE EAST & AFRICA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 91

TABLE 132 MIDDLE EAST & AFRICA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 91

TABLE 133 MIDDLE EAST & AFRICA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 92

TABLE 134 MIDDLE EAST & AFRICA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 92

TABLE 135 MIDDLE EAST PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 92

TABLE 136 MIDDLE EAST PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 93

TABLE 137 MIDDLE EAST PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 93

TABLE 138 MIDDLE EAST PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 93

TABLE 139 MIDDLE EAST PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 94

TABLE 140 AFRICA PCI MARKET BY PRODUCT TYPE, 2020 TO 2027 (USD MILLION) 94

TABLE 141 AFRICA PCI MARKET FOR CORONARY STENTS BY TYPE, 2020 TO 2027 (USD MILLION) 94

TABLE 142 AFRICA PCI MARKET FOR PTCA CATHETERS BY TYPE, 2020 TO 2027 (USD MILLION) 95

TABLE 143 AFRICA PCI MARKET FOR ACCESSORIES BY TYPE, 2020 TO 2027 (USD MILLION) 95

TABLE 144 AFRICA PCI MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 95

14 List Of Figures

FIGURE 1 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET: MARKET STRUCTURE 21

FIGURE 2 RESEARCH PROCESS 23

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 26

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET 28

FIGURE 5 SUPPLY CHAIN: GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET 32

FIGURE 6 GLOBAL PCI MARKET BY PRODUCT TYPE, 2020 & 2027 (USD MILLION) 37

FIGURE 7 GLOBAL PCI MARKET BY END-USER, 2020 & 2027 (USD MILLION) 43

FIGURE 8 GLOBAL PCI MARKET BY REGION, 2020 (%) 47

FIGURE 9 GLOBAL PCI MARKET BY REGION, 2020 & 2027 (USD MILLION) 47

FIGURE 10 AMERICAS PCI MARKET BY REGION, 2020 (%) 49

FIGURE 11 NORTH AMERICA PCI MARKET BY COUNTRY, 2020 (%) 52

FIGURE 12 EUROPE PCI MARKET BY REGION, 2020 (%) 60

FIGURE 13 WESTERN EUROPE PCI MARKET BY COUNTRY, 2020 (%) 63

FIGURE 14 ASIA-PACIFIC PCI MARKET BY COUNTRY, 2020 (%) 77

FIGURE 15 MIDDLE EAST & AFRICA PCI MARKET BY REGION, 2020 (%) 90

FIGURE 16 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, MARKET SHARE ANALYSIS, 2020 (%) 97

Markt für perkutane Koronarinterventionen

Der Markt für perkutane Koronarinterventionen wird voraussichtlich eine jährliche Wachstumsrate von 7,2% verzeichnen und wurde auf 6,64 Milliarden US-Dollar geschätzt.

セグメンテーション

製品タイプ別 Coronary Stents Ptca Catheters Coronary Guidewire And Accessories
エンドユーザー別 Hospitals & Specialty Clinics Ambulatory Surgical Centers Research And Academic Institutes And Others

キープレーヤー

  • Abbott (US)
  • ASAHI INTECC Company Limited (Japan)
  • B. Braun Melsungen AG (UK)
  • Biosensors International Group
  • Ltd (Singapore)
  • BIOTRONIK (US)
  • Boston Scientific Corporation (US)
  • C. R. Bard
  • Inc. (US)
  • Comed BV (Netherlands)
  • Cook (US)
  • Cordis (US)
  • Medtronic PLC (US)
  • Meril Lifesciences Pvt. Ltd (India)
  • Merit Medical System ( Utah)
  • and Terumo Corporation ( Japan)

運転手

  • Increasing Preference For Minimally Invasive Procedures
  • Increasing Geriatric Population
Speak to Analyst Request a Free Sample

Der globale Markt für perkutane Koronarinterventionen wird voraussichtlich eine jährliche Wachstumsrate von 7,1% verzeichnen soll bis 2023 15.205,4 Mio. USD erreichen. Die perkutane Koronarintervention (PCI) ist ein Verfahren zur Behandlung der Verengung der Koronararterien. Bei diesem Verfahren wird ein Katheter verwendet, um eine kleine Struktur zu platzieren, d.h. einen Stent, um Blutgefäße im Herzen zu öffnen, die sich aufgrund von Plaquebildung verengt haben.


Faktoren wie die zunehmende Prävalenz von Herzerkrankungen, die steigende Präferenz für minimalinvasive Verfahren und die wachsende geriatrische Bevölkerung, die anfälliger für diese Krankheiten ist, werden voraussichtlich das Wachstum des Marktes im Prognosezeitraum vorantreiben. Die strengen staatlichen Vorschriften in Bezug auf das Verfahren können jedoch das Wachstum des Marktes behindern.


Dynamik des Marktes


Die zunehmende Prävalenz von Herzerkrankungen wurde als eine der häufigsten Todesursachen bei Männern und Frauen angesehen. in den letzten Jahren. Die perkutane Koronarintervention (PCI) wird unter anderem zur Behandlung von akutem Herzinfarkt, zur Linderung von Angina pectoris (Herzschmerzen), zur Vorbeugung von Herzinfarkten und zur Linderung von kongestiver Herzinsuffizienz eingesetzt. PCI hat in den letzten Jahren aufgrund der zunehmenden Prävalenz koronarer Herzkrankheiten an Bedeutung gewonnen. Laut der European Cardiovascular Disease Statistics 2017 verursachen Herz-Kreislauf-Erkrankungen (CVD) jedes Jahr 3,9 Millionen Todesfälle in Europa und über 1,8 Millionen Todesfälle in der Europäischen Union (EU). Darüber hinaus sind Herz-Kreislauf-Erkrankungen für etwa 45% aller Todesfälle in Europa und 37% aller Todesfälle in der EU verantwortlich. Eine so große Bevölkerung, die an einer Nierenerkrankung leidet, kurbelt das Marktwachstum im Prognosezeitraum an.


Globaler Markt für perkutane Koronarinterventionen, nach Endverbrauchern, 2017 und 2023 (Mio. USD) Percutaneous coronary intervention Market


Quelle: MRFR-Analyse


Segmentierung


Der globale Markt für perkutane Koronarinterventionen wurde nach Produkttyp in Koronarstents, PTCA-Katheter, Koronarführungsdraht und Zubehör unterteilt. Basierend auf dem Endverbraucher wurde der Markt für perkutane Koronarinterventionen als Krankenhäuser und Spezialkliniken, ambulante chirurgische Zentren, Forschungs- und akademische Institute und andere eingestuft.


Globaler Marktanteil der perkutanen Koronarintervention, 2017 (%) Percutaneous coronary intervention Market


Quelle: MRFR-Analyse


Regionale Analyse


Der globale Markt für perkutane Koronarinterventionen, basierend auf der Region, wurde in Amerika, Europa, den asiatisch-pazifischen Raum sowie den Nahen Osten und Afrika unterteilt.


Amerika wird voraussichtlich den größten Anteil am globalen Markt für perkutane Koronarinterventionen halten. Es wird erwartet, dass Nordamerika den Markt dominieren wird, hauptsächlich aufgrund des zunehmenden Bewusstseins und der wachsenden Akzeptanz perkutaner Koronarinterventionstechniken.


Europa wird im Prognosezeitraum voraussichtlich den zweitgrößten Marktanteil ausmachen. Die Faktoren, die für das Marktwachstum in dieser Region verantwortlich sind, sind eine erhöhte Anzahl von Krankenhausaufenthalten wegen perkutaner koronare Interventionstechniken wie Angioplastie der Halsschlagader und zerebrale Angioplastie. Laut einer im Juni 2015 von der Organisation für wirtschaftliche Zusammenarbeit und Entwicklung (OECD) veröffentlichten Zeitschrift gab es in Polen 3,6 Zentren für perkutane Koronarintervention (PCI) pro Million Einwohner. Europa hält einen Marktanteil von 31% auf dem globalen Markt für perkutane Koronarinterventionen.


Der

asiatisch-pazifische Raum wird aufgrund der zunehmenden Prävalenz von Herz-Kreislauf-Erkrankungen in Verbindung mit der Entwicklung der Gesundheitsinfrastruktur und dem steigenden verfügbaren Einkommen als die am schnellsten wachsende Region auf dem Weltmarkt geschätzt.


Es wird erwartet, dass der Markt für perkutane Koronarinterventionen im Nahen Osten und in Afrika aufgrund der hohen Prävalenz der perkutanen Koronarintervention in Saudi-Arabien, Kuwait und den Vereinigten Arabischen Emiraten wachsen wird.


Die wichtigsten Akteure


Die wichtigsten Akteure auf dem globalen Markt für perkutane Koronarinterventionen sind Abbott (USA), ASAHI INTECC Company Limited (Japan), B. Braun Melsungen AG (UK), Biosensors International Group, Ltd (Singapur), BIOTRONIK (USA), Boston Scientific Corporation (USA), C. R. Bard, Inc. (USA), Comed BV (Niederlande), Cook (USA), Cordis (USA), Medtronic PLC (USA), Meril Lifesciences Pvt. Ltd (Indien), Merit Medical System (Utah) und Terumo Corporation (Japan).


Einige der wichtigsten Strategien, die von Akteuren auf dem globalen Markt für perkutane Koronarinterventionen verfolgt wurden, waren Innovation, Produktentwicklung sowie Akquisition und Fusionen.



  • Im Januar 2017 gab Abbott bekannt, dass es die Übernahme von St. Jude Medical, Inc. abgeschlossen hat und das Unternehmen zu einem führenden Unternehmen im Bereich der Medizinprodukte gemacht hat.



  • Im Juni 2016 brachte ASAHI INTECC Company Limited den ASAHI Caravel-Mikrokatheter in den USA auf den Markt. Dieser Start gab Caravel das niedrigste Kreuzungsprofil aller rein geflochtenen Mikrokatheter in den USA.



  • Im April 2017 gaben B. Braun Medical und Christie Medical Holdings, Inc. die Zusammenarbeit bekannt, die darauf abzielt, den Zugang zu Peripheral IV zu verbessern.


Marktsegmentierung


Globaler Markt für perkutane Koronarinterventionen, nach Produkttyp



  • Koronare Stents

  • PTCA-Katheter

  • Koronarer Ratgeber

  • Accessoires


Globaler Markt für perkutane Koronarinterventionen, nach Endverbrauchern



  • Krankenhäuser & Spezialkliniken

  • Ambulante chirurgische Zentren

  • Forschungs- und Wissenschaftsinstitute

  • Andere


Globaler Markt für perkutane Koronarinterventionen, nach Regionen



  • Americas

    • Nordamerika

      • US

      • Kanada



    • Lateinamerika





  • Europa

    • Westeuropa

      • Deutschland

      • Vereinigtes Königreich

      • Frankreich

      • Italien

      • Spanien

      • Rest Westeuropas



    • Ost-Europa





  • Asien-Pazifik

    • China

    • Japan

    • Indien

    • Australien

    • Südkorea

    • Rest von Asien-Pazifik





  • Naher Osten und Afrika

    • Naher Osten

    • Afrika




Verfügbare zusätzliche Anpassungen



  • Unternehmensprofile anderer wichtiger Akteure

    • JOHNSON & Johnson

      Report Scope:
      Report Attribute/Metric Details
        Market Size   USD 15,205.4 Million
        CAGR   7.1%
        Base Year   2019
        Forecast Period   2027
        Historical Data   2018
        Forecast Units   Value (USD Million)
        Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
        Segments Covered   Product Type, End User and Region
        Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
        Key Vendors   Abbott (US), ASAHI INTECC Company Limited (Japan), B. Braun Melsungen AG (UK), Biosensors International Group, Ltd (Singapore), BIOTRONIK (US), Boston Scientific Corporation (US), C. R. Bard, Inc. (US), Comed BV (Netherlands), Cook (US), Cordis (US), Medtronic PLC (US), Meril Lifesciences Pvt. Ltd (India), Merit Medical System ( Utah), and Terumo Corporation ( Japan)
        Key Market Opportunities   Favorable Reimbursement Scenario
        Key Market Drivers

    • Rising Prevalence Of Heart Diseases
    • Increasing Preference For Minimally Invasive Procedures
    • Increasing Geriatric Population


    • Speak to Analyst Ask for Customization

      Frequently Asked Questions (FAQ) :

      Percutaneous coronary intervention market projected to grow at approximately 7.1% CAGR during the assessment period (2020-2027).

      The valuation of the global percutaneous coronary intervention market is estimated to increase to USD 15,205.4 MN by the end of 2023.

      In addition to the rising prevalence of chronic heart diseases, the increasing adoption of PCI procedures performed on patients with coronary artery disease and rising funding for R&D & clinical trials are major tailwinds pushing the growth of the global percutaneous coronary intervention market.

      North America holds the largest share in the global percutaneous coronary intervention market, followed by Europe and the Asia Pacific, respectively.

      Abbott (U.S.), Boston Scientific Corporation (U.S.), ASAHI INTECC Company Limited (Japan), Cordis (U.S.), Cook Medical (U.S.), Comed B.V. (The Netherlands), C. R. Bard, Inc. (U.S.), Biosensors International Group, Ltd. (Singapore), Meril Lifesciences Pvt Ltd. (India), Terumo Corporation (Japan), Medtronic Plc. (U.S.), B BIOTRONIK (U.S.), Braun Melsungen AG (Germany), and Merit Medical System (U.S.), are some of the top players operating in the global percutaneous coronary intervention market.

Global Percutaneous Coronary Intervention Market: Company Landscape


The Global Percutaneous Coronary Intervention Market is dominated by several market players such as Abbott, B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, Medtronic Plc, and others. Major players in the percutaneous coronary intervention market are opting for strategic collaborations and partnerships, and new product launches to brace their position in the market.


Abbott accounted for the largest share in the global percutaneous coronary intervention market in the year 2017. The company employs a strategy of focusing on severe diseases, maintaining the quality of products by maximum automation and rising investment in research and development which helps the company in maintaining its market position. Additionally, the company is engaged in new product launches and strategic partnerships. For instance, in October 2017, Abbott announced an updated version of everolimus-eluting, metallic stent Xience with a new stent design, a new delivery system, and unique sizes. Also, in January 2017, the company announced that it had completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena.



  1. Braun Melsungen AG held the second largest share in the global percutaneous coronary intervention market in the year 2017. The company operates in four major divisions, namely, hospital care, Aesculap, outpatient market, and B. Braun Avitum, and has a wide range of products with about 5,000 products, out of which 95% of the products are manufactured by the company. Furthermore, the company is engaged in strategic collaborations and mergers which facilitates it to strengthen its position and expand its market presence globally. For instance, in April 2017, B. Braun Medical and Christie Medical Holdings, Inc. announced a collaboration aimed at improving the access of peripheral intravenous catheters.


Boston Scientific Corporation held a prominent share in the year 2017. The company works collaboratively to resolve the toughest problems of healthcare industries by developing solutions for patients suffering from life-threatening circumstances. The company focuses on developing high-quality products by using less invasive techniques. High customer satisfaction level, exceptional performance in new markets, and strong brand portfolio add to the company’s competitive advantage. In October 2015, the company received the Food and Drug Administration (FDA) approval for SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System for the treatment of coronary artery disease. With this approval, the company gained the rights to market the product in the US.


Medtronic is also a renowned player in the global percutaneous coronary intervention market. With the acquisition of Covidien, Medtronic has augmented its ability to create meaningful innovations for hospitals and healthcare providers so that it can deliver the best care possible to patients around the world. The company focuses on new product launches for the expansion of its product portfolio. For instance, in February 2018, Medtronic launched the first 2.0 mm Drug-Eluting stent Resolute Onyx in the US. The new product is intended to help interventional cardiologists treat patients with coronary artery disease (CAD) who have small vessels.


Terumo Medical Corporation is one of the major companies in the market. The company has successfully integrated small companies through mergers and acquisitions to build a strong supply chain network. By doing this, the company aims at strengthening its position in the market. For instance, in July 2018, the company acquired China-based Essen Technology to enter the drug-eluting stent market in China.


Cordis is one of the key companies having unmatched offerings in cardiology devices. The company was acquired by Cardinal Health in October 2015. The company focuses on strategic partnerships and new innovative product launches for its expansion in the market. For instance, in October 2016, the company announced several new strategic distribution agreements in the interventional vascular business for the expansion of its product portfolio in selected countries. Also, in November 2017, Cordis and Medinol announced the US Food and Drug Administration (FDA) approval of the EluNIR drug-eluting stent (DES) for the treatment of patients with narrowing or blockages to their coronary arteries.


Other companies in the percutaneous coronary intervention market are Cook Medical, C. R. Bard, Inc., Comed B.V., and Meril Lifesciences Pvt. Ltd, among others.